Suprima ENT throat tablets. Suprima - ENT - successful treatment of throat diseases

Trade name: SUPRIMA-ENT

INN: 2,4-dichlorobenzyl alcohol, amylmetacresol

Dosage form:

Lozenges with orange, lemon, honey and lemon, strawberry or eucalyptus flavors.

Compound:

Each tablet contains:
Active substances -
2, 4-dichlorobenzyl alcohol………. 1.2 mg,
amylmetacresol………………………. 0.6 mg.
Excipients: sugar, liquid glucose, citric acid, menthol, coloring, flavoring.

Pharmacotherapeutic group:

antiseptic, antimicrobial combined agent.
ATS code: R02AA20

Pharmacological properties:

Combined antiseptic drug for local use in the oral cavity and pharynx. Has an antimicrobial effect. Active against gram-positive and gram-negative microorganisms. Due to low systemic absorption, there are no data on the pharmacokinetics of SUPRIMA-ENT.

Indications for use:

It is used for the symptomatic treatment of infectious and inflammatory diseases of the oral cavity and pharynx. The effectiveness of the drug is due to the presence of two broad-spectrum antibacterial components.

Contraindications:

Hypersensitivity to the components of the drug.

Warnings:
Do not exceed the indicated dose.
When prescribing to patients with diabetes, it is necessary to take into account that the tablets contain sugar.

Directions for use and dosage:
Recommended for adults and children over 6 years old.
When the first symptoms of inflammation in the oral cavity and pharynx appear, it is recommended:
Adults - 1 tablet every 2 hours
The maximum daily dose is 8 tablets.
Children over 6 years old - 1 tablet every 4 hours.
The tablet should be dissolved until completely dissolved.

Interaction with other medicinal substances:
No clinically significant interactions between the drug SUPRIMA-ENT and drugs from other groups have been identified.

Side effects:
When used according to indications in recommended doses, no side effects of the drug were noted.

Release form:

lozenges with orange flavor, lemon flavor, honey and lemon flavor, strawberry flavor, eucalyptus flavor.

Storage conditions:

In a dry place, at a temperature not exceeding 25°C.
Keep out of the reach of children.

Best before date:

3 years.
Do not use the drug after the expiration date indicated on the package.

Manufacturer:

SHREYA LIFE SCIENCES Pvt. Ltd., India.

Dispensed without a doctor's prescription.

Dichlorobenzyl alcohol, amylmetacresol, sucrose, citric acid, dextrose, various dyes (honey-lemon, orange, eucalyptus, lemon, strawberry, pineapple, menthol, raspberry).

Release form

Lozenges with orange flavor in a strip of 4 tablets in a cardboard package No. 16.

Pharmacological action

Antimicrobial, antiseptic, anti-inflammatory, analgesic.

Pharmacodynamics and pharmacokinetics

Pharmacodynamics

Suprima-ENT belongs to the group of oral antiseptic drugs, widely used in the treatment of dental and otolaryngological infectious and inflammatory diseases. It contains two active components: 2,4-dichlorobenzyl alcohol - widely used as an antiseptic. The antiseptic effect is due to its ability to slow down the supply of water to pathogenic microflora cells, which slows down the process of their growth and reproduction and partial death.

Amylmetacresol - a derivative, causes coagulation of the intracellular protein of microorganisms, which disrupts the process of its synthesis, and as a result, slows down the growth and reproduction of microorganisms. Amylmetacresol It also has a mild local anesthetic effect.

Various essential oils included in its composition reduce the intensity of cough and improve nasal breathing. Suprima-ENT exhibits a pronounced antiseptic effect against both gram-positive and gram-negative microflora, and also has a fungicidal effect on fungi of the genus Candida .

Thanks to this spectrum of pharmacological action, the drug can be used not only as a therapeutic agent for diseases of the pharynx and oral cavity of infectious origin, but also used for prophylactic purposes. The drug effectively reduces pain, nasal congestion, and irritation of the mucous membrane of the upper respiratory tract.

Pharmacokinetics

No data available.

Indications for use

In the complex therapy of diseases of the pharynx and oral cavity of infectious and inflammatory origin (,).

Contraindications

High sensitivity to the drug, age up to 6 years. The use of Suprima Lor during pregnancy is possible only according to indications under the supervision of a physician.

Side effects

Suprima-Lor, instructions for use (Method and dosage)

Suprima-Lor tablets must be dissolved until they are completely dissolved. Take when early symptoms appear. Dosage: 1 tablet every 2 hours; for children after six years of age, the interval between doses increases to 4 hours. Do not exceed the maximum dosage - 8 tablets/day.

Overdose

Interaction

No clinically significant interactions between Suprima-ENT and other drugs have been identified.

Terms of sale

Over-the-counter sale.

Storage conditions

At a temperature of 10-25°C.

Best before date

Analogues

Level 4 ATX code matches:

Drugs with similar pharmacological effects include: Astrasept , Dinstrill , Gorpils , Septoral , Lightel , Dinstril-Lemon Elphasept , Terasil and others.

Reviews about Suprima-Lor

Reviews of the drug among patients are good. Most of them note that the drug relieves inflammation in the throat and oral cavity well.

« ... With the onset of cold weather, colds begin in our family. The throat most often suffers, the doctor advised Suprima-Lor. I bought it and don’t regret it. Significantly relieves throat discomfort».

Some complain that they cannot find Suprima-Lor ointment. This is not surprising, since this drug is not available in this dosage form. Many people confuse this drug with ointment Suprima-Plus , which is produced by the same manufacturer. This ointment has other active ingredients and is used externally.

Suprima-Lor price, where to buy

The price of Suprima-ENT tablets No. 16 varies between 85-103 rubles per pack. You can purchase it in the Moscow pharmacy chain without difficulty.

Online pharmacies in Russia Russia

ZdravCity

Suprima-Lor tablets for rassas. strawberries 16 pcs. Shreya Life Sciences Pvt.Ltd

Suprima-Lor tablets for rassas. honey-lemon 16 pcs. Shreya Life Sciences Pvt.Ltd

Suprima-Lor tablets for rassas. orange 16 pcs. Shreya Life Sciences Pvt.Ltd

Suprima-ENT (Suprima-LOR)

Compound

1 lozenge of Suprima-ENT contains:

active components:

2,4-dichlorobenzylic alcohol (Spiritus dichlorobenzylicus) – 1.2 mg,
amylmetacresol (Amylmetacresolum) – 0.6 mg;

excipients: sugar, liquid glucose, citric acid, menthol. The coloring and flavoring contents vary depending on the flavor of the tablets.

Pharmacological action

The drug Suprima-ENT is a prominent representative of oral antiseptics, which are used for infectious and inflammatory diseases in dentistry and otolaryngology.

One of the active components of the drug, 2,4-dichlorobenzyl alcohol (2,4-DCBS), is very widely used in medicine as an antiseptic. The manifestation of the antiseptic effect occurs due to the ability to prevent the flow of water into the cells of microorganisms, resulting in a delay in growth and reproduction, as well as the death of microorganism cells (bactericidal and bacteriostatic pharmacological activity). There is also evidence of the ability of 2,4-DCBS to affect respiratory syncytial and coronaviruses, but it has no effect on rhinoviruses and adenoviruses.

Amylmetacresol is a phenol derivative by chemical nature. It promotes the coagulation of protein inside the cells of microorganisms, which makes it impossible to synthesize it, as a result of which the growth and ability to reproduce microbial cells slows down until they die. The above mechanism of action of the substance contributes to the manifestation of pronounced antimicrobial activity. Amylmetacresol also exhibits a local anesthetic therapeutic effect.

Thanks to the presence of essential oils, Suprima-ENT facilitates nasal breathing and reduces the intensity of cough, providing a softening effect in areas of inflammation.

The drug Suprima-ENT, due to the combination of two components in its composition that exhibit a pronounced antiseptic (antibacterial) effect, which, moreover, is enhanced by the presence of mutual synergistic properties of both components, exhibits pronounced activity against many gram-positive and gram-negative microorganisms (staphylococcus, diplococcus, Klebsiella, Proteus and other aerobic and anaerobic pathogens). Suprima-ENT is also capable of having a fungicidal effect against fungi of the genus Candida - this fact is another positive characteristic of the drug, since inflammation of the mucous membrane of the mouth and throat is very often accompanied by candidiasis.

Thus, the drug Suprima-ENT is a combination drug with pronounced antiseptic, analgesic, local anesthetic and anti-inflammatory activity. Due to its wide range of pharmacological effects, Suprima-ENT is used both for preventive purposes and for the treatment of various kinds of infectious and inflammatory diseases in the oral cavity and pharynx, accompanied by pain and other symptoms that cause discomfort and significantly reduce the quality of life. The drug reduces pain and sore throat, nasal congestion, relieves irritation of the mucous surface of the upper respiratory tract.

Displaying preventive properties, the drug Suprima-ENT prevents the fixation (localization) and reproduction of bacteria entering the body (mainly by airborne droplets) on the mucous membrane of the mouth and throat.

Also, the drug Suprima-ENT is effective in the event of inflammatory processes occurring in dental practice (stomatitis, periodontal disease, pain as a result of various dental procedures).

The results of studies conducted during the development of the drug indicated the presence of an antiviral effect. Therefore, the use of Suprima-Lor is relevant not only in the case of inflammatory diseases of the oral cavity and throat of a bacterial or fungal nature, but also of viral etiology.

The pharmacokinetics of the drug has not been studied, because the active components are practically not absorbed into the body and do not enter the systemic circulation and, thus, do not have a negative effect, but have a local therapeutic effect.

Indications for use

The drug Suprima-Lor is used for preventive and therapeutic purposes against infectious and inflammatory diseases of the oral cavity and pharynx of a bacterial, fungal or viral nature (including in dental practice). It is prescribed to eliminate characteristic symptoms (pain and sore throat, cough, nasal congestion, dental pain, etc.). Suprima-ENT is indicated for the following diseases:

angina;
tonsillitis;
pharyngitis;
nasopharyngitis;
laryngitis (including professional laryngitis, which occurs when the vocal cords are overstrained);
stomatitis;
gingivitis;
periodontal disease;
pain syndrome caused by various dental procedures.

Directions for use

The drug Suprima-Lor is intended for patients aged 6 years and older. Take the drug orally. The tablet must be dissolved in the mouth until completely dissolved.

After taking the drug, it is undesirable to drink or eat for at least 15–20 minutes, otherwise the therapeutic effect is significantly reduced, since the drug, which is localized and acts in places of inflammation on the oral mucosa, leaves the localization sites along with food and drinks.

Unless the doctor prescribes otherwise, the drug is taken in accordance with the dosage schedule below:

adults and children over 12 years old, 1 tablet every 2 hours. The highest daily dose (IDD) of the drug is 8 tablets;
children over 6 years old: 1 tablet every 4 hours. IRR is 4 tablets.

Caution is required when used in patients with a history of diabetes mellitus, since Suprima-ENT contains sugar.

Suprima-ENT does not have a negative effect on the speed of psychomotor reactions and concentration.

Contraindications

Taking the drug Suprima-ENT is not allowed:

if there is sensitivity to the components of the drug;
children under 6 years old;
with a history of diabetes mellitus.

Pregnancy

There are no data from clinical studies in pregnant women due to the possibility of harm to the newborn. Therefore, the use of the drug Suprima-ENT is possible during pregnancy and lactation as prescribed by a doctor and only in consultation with a gynecologist.

Drug interactions

Studies have confirmed the absence of clinically significant interactions between Suprima-ENT and other drugs, but only if the recommended dosage regimen is followed. The absence of drug interactions occurs due to the very low percentage of drug absorption into the systemic circulation.

Overdose

If these symptoms are present, you should immediately stop taking the drug, seek medical help and continue the prescribed symptomatic treatment.

Release form

Suprima-Lor is available in the form of lozenges, which are available in a range of different flavors:

orange;
lemon;
honey-lemon;
strawberry;
eucalyptus;
raspberry;
pineapple;
menthol.

4 or 8 tablets each. in a strip (aluminum) – 4 (2) in a cardboard box.

Depending on the flavor, the tablets vary in color, but all tablets are round in shape. When determining the physical properties of tablets, the manufacturer allows for inhomogeneity of color and uneven surface of the tablet, as well as the presence of small air bubbles in the caramel mass and a white coating on the surface of the tablet.

Storage conditions

Store in a dry place, out of reach of children, at a temperature not exceeding 25°C. Shelf life – 3 years.

Synonyms

Strepsils, Agisept, Astrasept, Gorpils, Dinstril, Lightel, Lorisils, RinzaLorcept, Terasil, Voka Sept.

Nosological classification (ICD-10)

Acute pharyngitis (J02)

Acute tonsillitis (J03)

Acute upper respiratory tract infection of multiple and unspecified localization (J06)

In this article you can read the instructions for use of the drug Suprima. Reviews of site visitors - consumers of this medicine, as well as the opinions of specialist doctors on the use of Suprima in their practice are presented. We kindly ask you to actively add your reviews about the drug: whether the medicine helped or did not help get rid of the disease, what complications and side effects were observed, perhaps not stated by the manufacturer in the annotation. Analogues of Suprima in the presence of existing structural analogues. Use for the treatment of bronchitis, laryngitis, pharyngitis and other inflammatory diseases of the mouth and throat in adults, children, as well as during pregnancy and lactation. Composition of the drug.

Suprima- a complex herbal medicine with bronchodilator, mucolytic, expectorant and anti-inflammatory effects (Broncho).

Suprima COF is a mucolytic agent. Stimulates prenatal development of the lungs (increases synthesis, secretion of surfactant and blocks its breakdown). Has secretomotor, secretolytic and expectorant effects; stimulates the serous cells of the glands of the bronchial mucosa, increases the content of mucous secretion and the release of surfactant in the alveoli and bronchi; normalizes the disturbed ratio of serous and mucous components of sputum.

By activating hydrolyzing enzymes and enhancing the release of lysosomes from Clark cells, it reduces the viscosity of sputum.

Increases the motor activity of the ciliated epithelium, increases mucociliary transport. After oral administration, the effect occurs within 30 minutes.

Suprima ENT is a combined antiseptic drug for local use in the oral cavity and pharynx. Has an antimicrobial effect. Active against gram-positive and gram-negative microorganisms.

The effectiveness of the drug is due to the presence of two broad-spectrum antibacterial components.

Pharmacokinetics

The effect of the drug Suprima-Broncho is the combined effect of its components, so pharmacokinetic studies are not possible.

Compound

Wasika adatoda extract + Licorice extract + Curcuma longa extract + Holy basil extract + Real ginger extract + Nightshade extract + Long pepper extract + Real cardamom extract + excipients (Suprima Broncho syrup).

Ambroxol hydrochloride + excipients (Suprima KOF tablets).

2,4-dichlorobenzyl alcohol + Amylmetacresol + excipients (Suprima ENT).

Camphor + Menthol + Eucalyptus oil + Thymol + Turpentine oil + excipients (Suprima Plus ointment).

Indications

Symptomatic therapy for inflammatory diseases of the respiratory tract accompanied by cough:

ARVI, influenza;
pharyngitis, laryngitis, tracheitis;
bronchitis, pneumonia;
initial stages of whooping cough;
bronchial asthma with difficult sputum discharge;
bronchiectasis.

Chronic respiratory diseases:

smokers' bronchitis;
lecturer's laryngitis.

Inflammatory diseases of the upper and lower respiratory tract, accompanied by cough, runny nose, feeling of nasal congestion (as part of complex therapy), as well as muscle pain.

Release forms

Syrup Suprima Broncho.

Suprima KOF tablets.

Lozenges Suprima ENT.

Suprima Plus ointment.

Instructions for use and method of use

Syrup

For adults and children over 14 years of age, the drug is prescribed 1-2 teaspoons (5-10 ml) 3 times a day.

Children from 6 to 14 years old - 1/2-1 teaspoon (2.5-5 ml) 3 times a day; from 3 years to 5 years - 1/2 teaspoon (2.5 ml) 3 times a day.

The course of treatment is 2-3 weeks.

KOF tablets

The drug is taken orally during meals, with a small amount of liquid.

Adults and children over 12 years of age are prescribed 30 mg 3 times a day in the first 2-3 days, then 30 mg 2 times or 15 mg 3 times a day. In severe cases of the disease, the dose is not reduced throughout the entire course of treatment.

Children aged 5-12 years are prescribed 15 mg 2-3 times a day.

ENT lozenges

When the first symptoms of inflammation in the oral cavity and pharynx appear, it is recommended: adults - 1 tablet every 2 hours. The maximum daily dose is 8 tablets. Children over 6 years old - 1 tablet every 4 hours.

The tablet should be dissolved until completely dissolved.

Ointment Plus

For external use only!

To eliminate symptoms of inflammatory diseases of the upper and lower respiratory tract, such as cough, runny nose, feeling of nasal congestion, rub into the skin of the chest and back 2-3 times a day.

For muscle pain, apply ointment to the painful area. For best results, it is recommended to cover the painful area with a warm bandage.

Do not apply to damaged skin areas.

Side effect

weakness;
headache;
diarrhea;
dry mouth;
constipation;
nausea, vomiting;
skin rash;
hives;
bronchospasm (for ointment);
allergic reactions to the components of the drug.

Contraindications

tendency to bronchospasm (for ointment)
1st trimester of pregnancy (KOF tablets);
children under 5 years of age (KOF tablets);
hypersensitivity to the components of the drug.

Use during pregnancy and breastfeeding

The use of the drug during pregnancy is possible only in cases where the expected benefit to the mother outweighs the potential risk to the fetus or child.

KOF tablets are prohibited for use in the 1st trimester of pregnancy.

Use in children

Suprima Broncho: Children from 6 to 14 years old - 1/2-1 teaspoon (2.5-5 ml) 3 times a day; from 3 years to 5 years - 1/2 teaspoon (2.5 ml) 3 times a day.

Suprima KOF: Children over 12 years of age are prescribed 30 mg 3 times a day in the first 2-3 days, then 30 mg 2 times or 15 mg 3 times a day. In severe cases of the disease, the dose is not reduced throughout the entire course of treatment. Children aged 5-12 years are prescribed 15 mg 2-3 times a day.

Special instructions

At the same time, according to indications, it is possible to use antimicrobial agents.

When prescribing the drug to patients with diabetes, it should be taken into account that Suprima Broncho in 5 ml of syrup (1 teaspoon) contains 1.5 g of sugar.

Drug interactions

The combined use of Suprima KOF with antitussive drugs (for example, containing codeine) leads to difficulty in sputum discharge while reducing cough.

Clinically significant interactions between Suprima Broncho and other drugs have not been described.

Analogues of the drug Suprima

The drug Suprima has no structural analogues for the active substance.

Analogs by pharmacological group (secretolytics):

Ambrobene;
Ambroxol;
Ambrosan;
Ambrosol;
Amtersol;
Ascoril;
Acetylcysteine;
ACC Long;
Bromhexine;
Bronchicum;
Bronchicum cough syrup;
Bronchipret;
Bronchostop;
Bronchotil;
Gedelix;
GeloMyrtol;
Gerbion;
Chest collection;
Breast Elixir;
Deflegmin;
Joset;
Dr. MOM;
Dr. Theiss;
Zedex;
Insti;
Carbocysteine;
Codelac Broncho;
Coldrex broncho;
Lazolvan;
Libexin Muco;
Linkas Balm;
Mukaltin;
Mukobene;
Mucosol;
Expectorant collection;
Pectusin;
Pertussin;
overslept;
Rinicold Broncho;
Sinupret;
Licorice root;
Solutan;
Stoptussin;
Suprima KOF;
Cough tablets;
Terpinhydrate;
Travisil;
Tussamag;
Tussin;
Tussin Plus;
Fervex for cough;
Flavamed;
Fluimucil;
Fluifort;
Halixol;
Erdomed.

If there are no analogues of the drug for the active substance, you can follow the links below to the diseases for which the corresponding drug helps, and look at the available analogues for the therapeutic effect.

Many colds are accompanied by a sore throat. It gets worse when a bacterial infection occurs. If the body can cope with viral pathologies on its own, then antibiotics and antiseptics will be needed to eliminate harmful microorganisms. Doctors often prescribe complex treatment. Doctors prescribe general medications (for oral or injection use) and topical medications (for treating the larynx). In today's article, you will be presented with instructions for using Suprima-ENT. You can learn a lot of useful things about this drug.

Description: types of the drug "Suprima"

The drug "Suprima-ENT" is produced by the manufacturer in several forms. The general line is called “Suprima”. It includes syrup, ointment and lozenges. Each drug has a separate purpose and method of use. All medications are sold without a prescription and have an affordable price. You can buy the following products at the pharmacy:

"Suprima-ENT" ointment. The instructions for use advise using this remedy for coughs, nasal congestion and muscle pain. Its trade name is "Suprima-plus".
"Suprima broncho". This medicine is available in syrup form. The remedy is used for coughs of various origins: pneumonia, bronchitis, laryngitis, tracheitis and so on.
"Suprima-ENT". The instructions for use recommend prescribing the tablets for diseases of the mouth and pharynx.

Composition of the drug "Suprima-ENT" and its cost

In addition to the described variations of the line, the Suprima-ENT tablets have a separate division. The medicine has different flavoring additives. But this does not change the principle of operation of the medication. The active ingredient in lozenges is amylmetacresol. Also, to prepare the drug, the manufacturer uses dextrose, sucrose, citric acid, levomenthol, dyes and appropriate flavorings.

At the pharmacy you can purchase medicine in the following flavors: menthol, orange, lemon, eucalyptus, pineapple, raspberry, honey and strawberry. All products cost approximately the same. 16 lozenges will cost you no more than 150 rubles. Please note that the medication is an antibiotic.

Indications for use

You already know that Suprima drugs are prescribed for infectious diseases. "Suprima-ENT" (syrup) instructions for use recommends use for the treatment of cough. The ointment is used for nasal congestion and as a warming agent. Lozenges can eliminate infectious manifestations in the throat and oral cavity. Together, this line of products accelerates recovery from viral and bacterial pathologies.

Instructions for use of “Suprima-ENT” (tablets) recommend using the product for the following diseases:

stomatitis;
gingivitis;
tonsillitis in acute and chronic form;
glossitis and pharyngitis;
tracheitis and laryngitis.

A medication is prescribed to prevent the development of infection after various manipulations, for example, tooth extraction.

In what situations is treatment contraindicated?

Any medicine in the Suprima line should not be used if you are sensitive to its components. Otherwise, each drug has its own limitations. Instructions for use "Suprima-ENT" do not recommend using tablets for children under 6 years of age. What other useful information can you find out? What does the instructions for use say about Suprima-ENT? During pregnancy, the use of the medicine is permissible only after prior consultation with a doctor. With his permission and after receiving individual recommendations, the expectant mother can take the medicine. The use of the drug during lactation has not been studied. There is no guarantee that the active ingredients will not pass to the baby through breast milk.

The instructions for use do not indicate that the medication should not be taken if you have diabetes. But doctors give such information. The drug contains sugar. Its impact can negatively affect the course of the disease. That is why it is so important not to self-medicate, but to contact a specialist with existing complaints.

Instructions for use: “Suprima-ENT” lozenges

The annotation states that each tablet should remain in the mouth until completely dissolved. It is unacceptable to crush the lozenge beforehand or chew it. When treating children, detailed explanations on this matter must be given.

Children are prescribed one lozenge every 4 hours. You can take no more than 6 lozenges per day. Adult patients can use the medication every 2 hours, but not more than 8 tablets per day. Treatment should begin as early as possible, at the first symptoms of the disease. In this case, the maximum effect will be achieved. You need to use the medicine for the period prescribed by the doctor. Doctors usually prescribe medication for 5-7 days. In some situations, one-day use is recommended (for example, after surgery).

Other forms of the drug "Suprima": instructions

How is the ointment and syrup of this line used? Instructions for use recommend applying the balm to the back, chest and neck. It is advisable to carry out the manipulation before going to bed. It is permissible to rub your feet to obtain a warming effect. It is important that the patient does not have a fever. "Suprima-plus" is used in children only after two years.

"Suprima-Broncho" is prescribed in a dose of 2.5-10 milliliters three times a day. The dose of medication depends on the age of the patient. In children, the medicine is used only after three years.

How does medicine work in tablets?

The instructions for use of Suprima-ENT indicate that its active ingredients are antibacterial components. They have an antiseptic and antimicrobial effect. The components are effective against gram-positive and gram-negative bacteria. The components have a wide spectrum of action. The manufacturer says that there is no data on the pharmacokinetics of the drug. This is explained by the fact that only small doses of active substances are able to be absorbed into the bloodstream.

When absorbed, the medicine affects microorganisms located in the oral cavity and pharynx. Lozenges increase salivation, which, in turn, helps cleanse the mucous membranes.

Side effects

About the drug "Suprima-ENT" instructions for use, reviews from consumers and doctors report the following: the medication is well tolerated by patients. Only in some cases do adverse reactions to its use occur. They are expressed by allergies. If you experience redness of the skin, itching or swelling, treatment should be stopped. Consult your doctor for further advice. Please note that the allergen may not be the active antibiotic, but an additional component or dye.

The use of the drug in large doses contributes to the appearance of nausea, vomiting or the development of diarrhea. These unpleasant consequences go away on their own after stopping the medication. Only in special cases can doctors prescribe sorbents.